Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Government of UK has announced an investment of £100m ($127m) to scale up manufacturing of Covid-19 vaccine and gene therapy in the country.
The investment will support the new Cell and Gene Therapy Catapult Manufacturing Innovation Centre for expediting the mass production of a successful Covid-19 vaccine.
Schedule to open in December next year, the Centre will have the capacity to manufacture millions of doses per month. In Braintree, Essex, England, the investment will help upgrade an existing facility into a fully-licensed manufacturing centre.